8. Eigene veröffentlichte Originalarbeiten zur Habilitations

8. Eigene veröffentlichte Originalarbeiten zur Habilitations

8.
Eigene veröffentlichte Originalarbeiten zur Habilitationsschrift a
8.1.
Importance of S100A2 and S100P for diagnosis of non-small cell lung carcinoma
is impaired by advanced tumour stages and neoadjuvant chemotherapy. Babett
Bartling, Grit Rehbein, Wolfgang Daniel Schmitt, Hans-Stefan Hofmann, RolfEdgar Silber, Andreas Simm. European Journal of Cancer 43 (2007) 1935-1943.
8.2.
Comparative application of antibody and gene array for expression profiling in
human squamous cell lung carcinoma. Babett Bartling, Hans-Stefan Hofmann,
Thomas Boettger, Gesine Hansen, Stefan Burdach, Rolf-Edgar Silber, Andreas
Simm. Lung Cancer 48 (2005) 145-154.
8.3.
Down-regulation of the receptor for advanced glycation end-products (RAGE)
supports non-small cell lung carcinoma. Babett Bartling, Hans-Stefan Hofmann,
Bernd Weigle, Rolf-Edgar Silber, Andreas Simm. Carcinogenesis 26 (2005) 293301.
8.4.
Proliferative stimulus of lung fibroblasts on lung cancer cells is impaired by
RAGE. Babett Bartling, Nina Demling, Rolf-Edgar Silber, Andreas Simm.
American Journal of Respiratory and Molecular Cell Biology 34 (2006) 83-91.
8.5.
Fibroblast-associated factors mediate induction of high mobility group box
protein 1 in lung epithelial cells. Babett Bartling, Christine Fuchs, Rolf-Edgar
Silber, Andreas Simm. International Journal of Molecular Medicine 20 (2007) 217224.
8.6.
Senescent fibroblasts induce moderate stress in lung epithelial cells in vitro.
Babett Bartling, Grit Rehbein, Rolf-Edgar Silber, Andreas Simm. Experimental
Gerontology 41 (2006) 532-539.
a
Aus urheberrechtlichen Gründen sind die Arbeiten in der veröffentlichten Version der
Habilitationsschrift nicht enthalten.
54